Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
US6552168B1 · kind B1 · utility
0Cited by
4References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 1999 |
| Grant date | Apr 22, 2003 |
| Priority date | — |
| Expiry date | Dec 2, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention encompasses the novel class of compounds represented by formula I, which are caspase-3 inhibitors. The invention also encompasses certain pharmaceutical compositions for treatment of caspase-3 mediated diseases comprising compounds of formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.